Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Update Regarding BNP Facility

29 May 2020 07:00

RNS Number : 2921O
Kropz PLC
29 May 2020
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

29 May 2020

Kropz Plc

("Kropz" or the "Company")

 

Update Regarding BNP Facility

 

Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, announces that, further to the announcement on 13 May 2020, Kropz Elandsfontein (Pty) Ltd ("Kropz Elandsfontein"), of which the Company holds a 74 per cent. interest, has now entered into a conditional amendment and restatement agreement with BNP Paribas SA ("BNP"). Kropz Elandsfontein and BNP have agreed to amend and restate the term loan facility agreement entered into on 13 September 2016 (as amended from time to time) ("BNP Facility"), whereby BNP had previously agreed to make available to Kropz Elandsfontein a credit facility of up to US$ 30 million ("BNP Facility Amendment Agreement").

 

As previously advised, the BNP Facility Amendment Agreement extends the final repayment date to Q3 2024, with eight capital repayments of US$ 3.75 million per quarter, expected to commence in Q4 2022 with an interest rate of 6.5% plus US LIBOR, up to project completion (expected to be December 2022) and 4.5% plus US LIBOR thereafter, payable quarterly. The BNP Facility remains fully drawn.

 

The BNP Facility Amendment Agreement remains conditional on customary conditions precedent, including the approval of the South African Reserve Bank which is expected in June 2020. Upon satisfaction of each of these conditions precedent, Kropz Elandsfontein will receive the necessary waiver of the technical default of the BNP Facility which was announced on 14 February 2020.

 

For further information visit www.kropz.com or contact:

Kropz Plc

 

Mark Summers (Interim CEO)

+27 (0)79 744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Richard Tonthat

Samantha Harrison

Niall McDonald

+44 (0)20 7383 5100

 

 

Hannam & Partners

Joint Broker

Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500

 

Mirabaud Securities Ltd

Joint Broker

Rory Scott

Edward Haig-Thomas

+44 (0)20 3167 7220

+44 (0)20 3167 7222

 

 

Tavistock

Financial PR & IR (UK)

Emily Moss

Jos Simson

Oliver Lamb

+44 (0)20 7920 3150

kropz@tavistock.co.uk

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

james@rasc.co.za 

About Kropz

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRPPUBGAUPUPUR
Date   Source Headline
23rd Jul 202112:29 pmRNSResult of General Meeting
19th Jul 20213:47 pmRNSUpdate regarding General Meeting Arrangements
9th Jul 20214:41 pmRNSSecond Price Monitoring Extn
9th Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20213:16 pmRNSIssue of LTIP Awards
30th Jun 20211:58 pmRNSResult of AGM
30th Jun 20217:00 amRNSFinal Results, Posting of Annual Report & Accounts
30th Jun 20217:00 amRNSTotal Voting Rights
16th Jun 20214:42 pmRNSSecond Price Monitoring Extn
16th Jun 20214:36 pmRNSPrice Monitoring Extension
16th Jun 20213:16 pmRNSEquity Facility Draw Downs
16th Jun 202111:05 amRNSSecond Price Monitoring Extn
16th Jun 202111:00 amRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSNotice of AGM and Corporate Update
25th May 20217:00 amRNSElandsfontein and Hinda Update
31st Mar 20217:00 amRNSTotal Voting Rights
3rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSEquity Facility Draw Downs
26th Feb 20217:00 amRNSNew Convertible Facility Agreement
16th Feb 202110:50 amRNSDisposal of Aflao Project
4th Feb 20217:00 amRNSHinda Update
2nd Feb 20217:00 amRNSElandsfontein Update
20th Jan 20217:00 amRNSElandsfontein Update regarding Water Tribunal
9th Dec 20207:00 amRNSEquity Facility Draw Down
30th Sep 20207:00 amRNSManagement Update
24th Sep 20207:00 amRNSEquity Facility Draw Down
9th Sep 20202:36 pmRNSEquity Facility Quarterly Draw Down Update
3rd Sep 20207:00 amRNSElandsfontein Update regarding Water Tribunal
28th Aug 202012:00 pmRNSResult of AGM
26th Aug 20207:00 amRNSUnaudited Half Year Results for H1 2020
20th Aug 20207:00 amRNSElandsfontein Update regarding Water Tribunal
6th Aug 20207:00 amRNSHinda Logistics Study
4th Aug 20207:00 amRNSCEO Appointment & Issue of LTIP Awards & Warrants
3rd Aug 20207:00 amRNSFinal Results, Annual Report and Notice of GM
29th Jun 20207:00 amRNSResults of Open Offer
25th Jun 20204:29 pmRNSEquity Facility & BNP Update & Share Issue
19th Jun 20207:00 amRNSOpen Offer & Equity Facility Update
12th Jun 20207:00 amRNSExtension of Open Offer Closing Date
10th Jun 20203:29 pmRNSEquity Facility Draw Down Update
1st Jun 20207:00 amRNSPlacing and Open Offer
29th May 202011:48 amRNSResults of GM and Equity Facility Draw Down
29th May 20207:00 amRNSUpdate Regarding BNP Facility
21st May 202012:35 pmRNSChange of Registered Office
13th May 20201:29 pmRNSEquity Facility, Proposed Fundraising & GM Notice
25th Mar 20207:00 amRNSCovid-19 Update and South African Directive
16th Mar 202011:46 amRNSElandsfontein Update
26th Feb 20207:01 amRNSCEO Resignation
26th Feb 20207:00 amRNSLoan Facility
14th Feb 20201:20 pmRNSCorporate and Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.